2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
"Selinexor+Pegaspargase+Dexamethasone"in Ⅰ/Ⅱ NKTCLextranodal nasal NK/T cell lymphomaRecruitingPhase 1 / Phase 22025-07-14NCT06559553
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell LymphomaNewly Diagnosed Diffuse Large B-cell LymphomaRecruitingPhase 1 / Phase 22024-11-12NCT06683885